Scientists around the world are regularly trying to find effective ways of therapy of incurable diseases. These include such terrible disease as cancer. We try to cover these topics and if you’re interested, you can subscribe to our news channel in the Telegram. Along with skin cancer, blood cancer is considered one of the most dangerous types of tumor formation. However, sometimes it happens that the drug is effective against one disease, and is effective against the other. For example, recently a group of scientists from the UK reported that the famous drug from arthritis can help in the treatment of blood cancer.
How to beat blood cancer
If we talk about cancer of the blood, it is quite common types of this disease, along with leukemia are polycythemia Vera and essential thrombocythemia. If you try to explain in simple words, these diseases are associated with excessive increase in the number of red blood cells or platelets (types of cells) of human blood. Normal of these cells must be a certain number, but when for one reason or another fails, there is nekontroliruem reproduction, which leads to the development of cancer of the blood.
This is interesting: What food causes cancer.
Modern methods of treatment of such conditions is usually aimed at reducing the content of blood cells, that is, roughly speaking, to “destroy” a certain number of cells, to gain indicators to normal. However, these methods only relieve symptoms, not affecting the root of the problem. In search of the cure a group of scientists from Sheffield University decided to investigate the drug methotrexate. This drug is used in the treatment of arthritis and other autoimmune diseases. The basic principle of its action is that methotrexate inhibits the susceptibility of cells to folic acid, thereby reducing their ability to ramnarine. Previously published evidence that methotrexate is effective against leukemia (another type of blood cancer), but its effects on polycythemia Vera and essential thrombocythemia has not been studied.
Laboratory research scientists from the UK have shown that low doses of methotrexate, acted as a “suppressor” processes of cell division blood cancer. However, this is only the first stage of the study as a control group recruited for the experiments were insignificant. Now experts want to carry out more large-scale soliciting of attracting a far greater number of patients. And if the data is confirmed, doctors will be another efficient and cheap means of therapy of dangerous diseases.
Because the production of methotrexate is well — established process, which the price is not so high when compared with other anticancer drugs. Doctors believe that methotrexate can become not only an auxiliary means of treatment, but full preparation for the relief of as symptoms of polycythemia and thrombocythemia, and as the means of choice in the treatment of oncological processesassociated with lesions of the blood.